The main objective of this study is to analyze the impact on the health-related quality of life of patients with refractory symptoms, who have been referred to the HUGCDN Chronic Pain Unit for adjuvant palliative treatment with ozone therapy between June-2022 and December-2025
Adults > = 18 years old.
Patients submitted to the Chronic Pain Unit of the Hospital Universitario de Gran Canaria Dr. Negrín for symptomatic/palliative treatment with ozone therapy because conventional treatment does not exist, it has been unsuccessful, or it is associated with high risk or high morbidity.
After evaluation of symptoms and patients, it exists a potential benefit of adding ozone treatment to the current treatment.
Patients have no contraindications for ozone treatment.
Age < 18 years old.
Psychiatric illness or social situations that would limit compliance with study requirements.
Those who are incapable to fill in the scales used to measure variables.
Hemodynamically or clinically unstable patients or uncontrolled severe illness.
Bernardino Clavo, MD, PhD
Lead sponsor
Dr. Negrin University Hospital
Sponsor institution
Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC)
Collaborator
Servicio Canario de Salud
Collaborator
Council of Gran Canaria
Collaborator
Red de Investigación en Servicios de Salud en Enfermedades Crónicas
Collaborator
Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna
Collaborator